antiretroviral therapy

How Pharmacists Are Helping Hep C Patients
How Pharmacists Are Helping Hep C PatientsA Walgreens study found that pharmacist collaboration helps Hep C patients with better outcomes and cheaper co-pays.
Non-adherence has big impact on Medicaid beneficiaries with HIVNew data presented at the International AIDS Society Conference examines the medical and financial burden of missing pills.
Pharmacist-directed care for HIV patients provides earlier viral suppressionHIV patients whose antiretroviral therapy was initiated and managed by pharmacists achieved earlier viral suppression compared with those managed by a primary HIV clinician, according a report published in the September 1 issue of the American Journal of Health-System Pharmacy.
Antiretroviral combination tablet approved for treatment of HIV-1FDA has approved the antiretroviral Prezcobix (darunavir 800 mg/cobicistat 150 mg, Janssen Therapeutics) for the treatment of human immunodeficiency virus 1 (HIV-1).
CDC releases guidelines for HIV preventive medsThe Centers for Disease Control and Prevention (CDC) released a new set of comprehensive guidelines that recommends that physicians should consider prescribing antiretroviral medication to individuals who are not infected with HIV but are at high risk of infection.
Pharmacists reduce Rx errors in HIV patientsA pharmacist’s participation on medical teams treating HIV-positive hospital patients reduces medication errors as well as spots and corrects them sooner, according to a report published in the Annals of Pharmacotherapy.
Fulyzaq improves noninfectious diarrhea in patients with HIV on ART therapyNoninfectious diarrhea in patients with HIV on antiretroviral therapy showed improvement after treatment with 125-mg delayed-release crofelemer (Fulyzaq, Salix Pharmaceuticals) tablets, according to a study in HIV Clinical Trials.
FDA approves new once-daily treatment option for HIVDolutegravir, a new, once-daily option, may allow improved personalization of a patient’s medication regimen.
New guide for managing HIV/AIDS-related infectionsGuidelines for preventing and treating HIV/AIDS-related opportunistic infections (OIs) in children recently received a facelift. Government agencies and industry associations banded together to update recommendations previously published in 2009.
The current state of HIV therapy [INFOGRAPHIC]Incidence of human immunodeficiency virus (HIV) has decreased dramatically since its emergence in the early 1980s, but it remains a worldwide epidemic. There is a reduction in newly diagnosed patients, but prevalence is increasing due to a longer life expectancy, which is attributed in part to highly effective antiretroviral therapies. Newly approved and investigational antiretroviral therapies provide additional options for the healthcare team to prevent progression of disease as well as transmission of HIV. Early detection and prevention of HIV is still paramount with the use of in-home HIV testing as well as antiretrovirals for pre-exposure prophylaxis. While many advances in HIV diagnosis and treatment have been made, the importance of education and risk avoidance cannot be underestimated.